HSP90-inhibiting triazole derivatives

Details for Australian Patent Application No. 2006215902 (hide)

Owner Merck Patent GmbH

Inventors Wolf, Michael; Eggenweiler, HansMichael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006215902

PCT Pub. Number WO2006/087077

Priority 10 2005 007 304.2 17.02.05 DE

Filing date 25 January 2006

Wipo publication date 24 August 2006

Acceptance publication date 8 December 2011

International Classifications

C07D 249/12 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/087077 Priority application(s): WO2006/087077

8 December 2011 Application Accepted

  Published as AU-B-2006215902

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006215925-Method for operating fuel cells for systems that are restricted by exposure to thermal stress and fuel cell stack for carrying out said method

2006215886-Method for producing spherical mixed oxide powders in a hot wall reactor